Adrian Parton
Directeur Général chez Matrix MicroScience Ltd.
Profil
Adrian Parton is the founder and is the Chief Executive Officer of Matrix MicroScience Ltd.
which is founded in 2000.
He is currently the Chairman of Inotec AMD Ltd.
and a Director of AB-Polyblok Ltd.
At Boundary Capital Partners LLP, he was a Partner from 2015 to 2022.
Postes actifs de Adrian Parton
| Sociétés | Poste | Début |
|---|---|---|
Matrix MicroScience Ltd.
 Matrix MicroScience Ltd. Medical SpecialtiesHealth Technology MATRIX MicroScience was established in August 2000, with a market focus on the development of rapid microbiological tests for the food industry and more recently expanded into the environmental and bio-threat sectors. Current testing methods for the detection of micro-organisms in food are labor intensive and slow, typically taking up to 5 days to obtain a result. For many food types, such as fresh produce and beef, this is of little use. In response to market demand, MATRIX has developed a novel patented system called PATHATRIX. Using RIMS (re-circulating immuno-magnetic separation) technology, PATHATRIX can specifically purify and detect pathogens directly from complex food matrices within hours. For priority cases, the PATHATRIX can be coupled with rapid detection systems to produce a result in as little as 5 hours from point of sample. PATHATRIX employs proven technology at its core that can easily be adopted in any microbiology laboratory, with a minimum of training. Unlike other rapid methods, viable cultures are produced which enable full and detailed analysis of any positive result to be carried out without any further manipulation. PATHATRIX can be used to enhance the performance and reduce the number of 'false positives' of other rapid methods such as PCR, ELISA, chromomeric media etc., and by significantly reducing or eliminating the need for lengthy enrichment and/or selective enrichment steps. The highly innovative Pathatrix Pooling, AOAC-RI approved protocol, provides the customer with dramatic (5x) increase in sample throughput and very significant (>60%) reduction in analysis costs and labor. Sample integrity is maintained 100% enabling the rapid positive identification of individual samples. Linked to rapid methods it provides real-time microbiology for faster product release and incident investigation. Pathatrix has been successfully deployed in real life Salmonella and E.coli O157 outbreaks from contaminated food and has enables food companies and regulatory authorities to rapidly identify the source of contamination. | Directeur Général | 03/05/2010 |
Inotec AMD Ltd.
 Inotec AMD Ltd. Medical SpecialtiesHealth Technology Inotec AMD Ltd. develops wound healing technologies. It provides solutions for chronic wounds, such as venous and pressure-induced leg ulcers and diabetic lesions. The company was founded by Melvin Frederick Vinton and Derek John Fray on December 23, 2003 and is headquartered in Cambridge, the United Kingdom. | Président | - |
AB-Polyblok Ltd.
 AB-Polyblok Ltd. Miscellaneous Commercial ServicesCommercial Services AB-Polyblok Ltd. provides drug therapy for the treatment of alzheimer’s disease. It offers revolutionary technology which has the potential to treat and potentially partially reverse, the effects of Alzheimer ’s disease. The company is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Adrian Parton
| Sociétés | Poste | Fin |
|---|---|---|
Boundary Capital Partners LLP
 Boundary Capital Partners LLP Investment ManagersFinance Boundary Capital Partners LLP (Boundary Capital) is a venture capital firm founded in 2009. The firm is headquartered in London. | Private Equity Investor | 01/07/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Matrix MicroScience Ltd.
Matrix MicroScience Ltd. Medical SpecialtiesHealth Technology MATRIX MicroScience was established in August 2000, with a market focus on the development of rapid microbiological tests for the food industry and more recently expanded into the environmental and bio-threat sectors. Current testing methods for the detection of micro-organisms in food are labor intensive and slow, typically taking up to 5 days to obtain a result. For many food types, such as fresh produce and beef, this is of little use. In response to market demand, MATRIX has developed a novel patented system called PATHATRIX. Using RIMS (re-circulating immuno-magnetic separation) technology, PATHATRIX can specifically purify and detect pathogens directly from complex food matrices within hours. For priority cases, the PATHATRIX can be coupled with rapid detection systems to produce a result in as little as 5 hours from point of sample. PATHATRIX employs proven technology at its core that can easily be adopted in any microbiology laboratory, with a minimum of training. Unlike other rapid methods, viable cultures are produced which enable full and detailed analysis of any positive result to be carried out without any further manipulation. PATHATRIX can be used to enhance the performance and reduce the number of 'false positives' of other rapid methods such as PCR, ELISA, chromomeric media etc., and by significantly reducing or eliminating the need for lengthy enrichment and/or selective enrichment steps. The highly innovative Pathatrix Pooling, AOAC-RI approved protocol, provides the customer with dramatic (5x) increase in sample throughput and very significant (>60%) reduction in analysis costs and labor. Sample integrity is maintained 100% enabling the rapid positive identification of individual samples. Linked to rapid methods it provides real-time microbiology for faster product release and incident investigation. Pathatrix has been successfully deployed in real life Salmonella and E.coli O157 outbreaks from contaminated food and has enables food companies and regulatory authorities to rapidly identify the source of contamination. | Health Technology |
Boundary Capital Partners LLP
Boundary Capital Partners LLP Investment ManagersFinance Boundary Capital Partners LLP (Boundary Capital) is a venture capital firm founded in 2009. The firm is headquartered in London. | Finance |
Inotec AMD Ltd.
Inotec AMD Ltd. Medical SpecialtiesHealth Technology Inotec AMD Ltd. develops wound healing technologies. It provides solutions for chronic wounds, such as venous and pressure-induced leg ulcers and diabetic lesions. The company was founded by Melvin Frederick Vinton and Derek John Fray on December 23, 2003 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
AB-Polyblok Ltd.
AB-Polyblok Ltd. Miscellaneous Commercial ServicesCommercial Services AB-Polyblok Ltd. provides drug therapy for the treatment of alzheimer’s disease. It offers revolutionary technology which has the potential to treat and potentially partially reverse, the effects of Alzheimer ’s disease. The company is headquartered in Cambridge, the United Kingdom. | Commercial Services |
